← Browse by Condition

Medical Condition

spinal cord injuries

Total Trials

29

Recruiting Now

29

Trial Phases

EARLY_Phase 1, Phase 2, Phase 3, Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for spinal cord injuries sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — spinal cord injuries Clinical Trials

How many clinical trials are currently recruiting for spinal cord injuries?

ClinicalMetric currently tracks 29 actively recruiting clinical trials for spinal cord injuries, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 29. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for spinal cord injuries?

spinal cord injuries research spans Phase 1 (3 trials), Phase 2 (3 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a spinal cord injuries clinical trial?

Eligibility criteria for spinal cord injuries trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

3

Phase 2

3

Phase 3

1

Top Sponsors

Spaulding Rehabilitation Hospital 2 trials

University of Zurich 2 trials

VA Office of Research and Development 2 trials

Shirley Ryan AbilityLab 1 trial

Afyonkarahisar Health Sciences University 1 trial

Recruiting Clinical Trials

Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone Technology and E-coaching

Shirley Ryan AbilityLab

Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients

Turkey (Türkiye)

Afyonkarahisar Health Sciences...

Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)

Kessler Foundation

Combination Therapy to Improve SCI Recovery.

Spaulding Rehabilitation Hospi...

Efficacy of rTMS Treatment After Spinal Cord Injury

Oslo University Hospital

Reticulospinal Control of Movements

University of Zurich

Combined Magnetic Stimulation and Ultrasound for Detrusor Overactivity in SCI

Shengjing Hospital

Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling

Austria, Belgium, Ch...

St George's, University of Lon...

The Impact of Expressive Emotional Writing on Facilitating Grief Resolution in Adults With Spinal Cord Injury

University of Alabama at Birmi...

Low Oxygen Therapy to Enhance Walking Recovery After SCI.

Spaulding Rehabilitation Hospi...

NCT05467215 EARLY_Phase 1

Can Brief Exposure to Hyperoxia Improve Function After Chronic Spinal Cord Injury?

University of Alberta

NCT04782947 Phase 2, Phase 3

Epidural Stimulation and Resistance Training After SCI

United States Department of De...

Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury

Hugo W. Moser Research Institu...

The Teaspoon Study - Telefitting Spinal Cord Stimulation for Pain

University of Minnesota

Prevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury

Loewenstein Hospital

Role of Endothelial Function in SCI CVD Risk

Functional and Structural Changes in the Central Nervous System Following Spinal Cord Injury

University of Zurich

A Feasible Smart Upper Limb Rehabilitation Model for Patients With Stroke and Spinal Cord Injuries

National Cheng-Kung University...

NCT06596291 Phase 1, Phase 2

Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

Cyllene Therapeutics

MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury

Columbia University

Artificial Intelligence Model for Traumatic Cervical Spinal Cord Injury Based on Radiomics and Genomics

Affiliated 2 Hospital of Nanto...

Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI

Medical University of South Ca...

Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury

University of Louisville

The Enteric Nervous System in Spinal Cord Injury: Study of the Enteric Nervous System and the Intestinal Epithelial Barrier Via Colonic Biopsies in Spinal Cord Injury Patients

Nantes University Hospital

Dosing rTMS for Depression Post-SCI

VA Office of Research and Deve...

NCT05317832 Phase 2

Using Smartphones to Improve Physical Activity Levels of Individuals With Spinal Cord Injury

Temple University

Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)

Leigh R. Hochberg, MD, PhD.

Multi-speed Ergonomic Wheelchair

VA Office of Research and Deve...

NCT06438471 Phase 1

Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

EicOsis Human Health Inc.

Related Conditions

neuropathic pain (3) spinal cord diseases (2) cardiovascular diseases (2) tetraplegia (2) neurological diseases or conditions (1) trauma nervous system (1) nervous system diseases (1) central nervous system diseases (1) hypotension (1) orthostatic hypotension (1) acute spinal cord injury (1) blood pressure (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology